MED-PHCVIVFeb 6, 2025

LUND-PROBE -- LUND Prostate Radiotherapy Open Benchmarking and Evaluation dataset

arXiv:2502.04493v22 citationsh-index: 21Sci Data
AI Analysis

This provides a valuable resource for researchers in medical imaging and prostate cancer radiotherapy, enabling work on automated planning and segmentation, though it is incremental as it builds on existing data-sharing efforts.

The authors introduced a public dataset of MRI and synthetic CT images, segmentations, and dose distributions for 432 prostate cancer patients to address the lack of accessible clinical data for machine learning in radiotherapy, with an extended set including DL-generated segmentations and uncertainty maps for 35 patients.

Radiotherapy treatment for prostate cancer relies on computed tomography (CT) and/or magnetic resonance imaging (MRI) for segmentation of target volumes and organs at risk (OARs). Manual segmentation of these volumes is regarded as the gold standard for ground truth in machine learning applications but to acquire such data is tedious and time-consuming. A publicly available clinical dataset is presented, comprising MRI- and synthetic CT (sCT) images, target and OARs segmentations, and radiotherapy dose distributions for 432 prostate cancer patients treated with MRI-guided radiotherapy. An extended dataset with 35 patients is also included, with the addition of deep learning (DL)-generated segmentations, DL segmentation uncertainty maps, and DL segmentations manually adjusted by four radiation oncologists. The publication of these resources aims to aid research within the fields of automated radiotherapy treatment planning, segmentation, inter-observer analyses, and DL model uncertainty investigation. The dataset is hosted on the AIDA Data Hub and offers a free-to-use resource for the scientific community, valuable for the advancement of medical imaging and prostate cancer radiotherapy research.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes